rAAVrh74.MCK.GALGT2

BIOLOGICAL2 trials

Sponsors

Kevin Flanigan

Conditions

Duchenne Muscular Dystrophy

Phase 1

Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2

WithdrawnNCT02704325

Kevin FlaniganDuchenne Muscular Dystrophy

Start: 2016-04-30End: 2020-02-29Updated: 2018-02-06

Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy

CompletedNCT03333590

Kevin FlaniganDuchenne Muscular Dystrophy

Start: 2017-11-06End: 2023-12-31Updated: 2025-03-13